Results 201 to 210 of about 6,940,670 (314)

Herpes simplex virus esophagitis in an immunodeficient patient with non-small-cell lung cancer following a disseminated herpes zoster infection [PDF]

, 2008
Felix Gundling, H. Rohrbach, Michael Nerlich, W. Schepp   +3 more
openalex   +1 more source

KLK7 overexpression promotes an aggressive phenotype and facilitates peritoneal dissemination in colorectal cancer cells

FEBS Open Bio, EarlyView.
KLK7, a tissue kallikrein‐related peptidase, is elevated in advanced colorectal cancer and associated with shorter survival. High KLK7 levels in ascites correlate with peritoneal metastasis. In mice, KLK7 overexpression increases metastasis. In vitro, KLK7 enhances cancer cell proliferation, migration, adhesion, and spheroid formation, driving ...
Yosr Z. Haffani, Tobias Dreyer, Meriem Naim, Rea Lo Dico, Natalia A. Ignatenko, Viktor Magdolen, Dalila Darmoul   +6 more
wiley   +1 more source

Erratum: 99mTc-octreotide Receptor Scintigraphy in NCI-H446 Small Cell Lung Cancer Nude Mice Model

Chinese Journal of Lung Cancer, 2015
Editorial Office of Chinese Journal of Lung Cancer
doaj   +1 more source

Erratum: Emerging Actions of Pterostilbene on Cancer Research

Chinese Journal of Lung Cancer, 2020
Editorial Office of Chinese Journal of Lung Cancer
doaj   +1 more source

Targeting ferroptosis to overcome drug resistance in lung cancer. [PDF]

Transl Lung Cancer Res
Sheng P, Jin J, Liu H, Sun C, Chen Y, Chen X, Ma D, Shen J.   +7 more
europepmc   +1 more source

Meloxicam inhibits the growth of non-small cell lung cancer

, 2005
Yasunori Tsubouchi, Yutaka Kawahito, Hajime Sano, Toshikazu Yoshikawa   +3 more
openalex   +2 more sources

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer.

New England Journal of Medicine, 2002
J. Schiller, D. Harrington, C. Belani, C. Langer, A. Sandler, J. Krook, Junming Zhu, David H. Johnson   +7 more
semanticscholar   +1 more source

Domain associated with zinc fingers‐containing NF90‐NF45 complex inhibits m6A modification of primary microRNA by suppressing METTL3/14 activity

FEBS Open Bio, EarlyView.
NF90–NF45 functions as a negative regulator of methyltransferase‐like 3/14 (METTL3/14)‐mediated N6‐methyladenosine (m6A) modification on primary microRNAs (pri‐miRNAs). NF90–NF45 binds to anti‐oncogenic pri‐miRNAs and inhibits their m6A modification, thereby suppressing the biogenesis of anti‐oncogenic miRNAs.
Takuma Higuchi, Shunsuke Morioka, Keiko Morisawa, Kazutsugu Matsukawa, Shingo Ashida, Takeshi Suzuki, Shuji Sakamoto   +6 more
wiley   +1 more source

Sevabertinib, a Reversible HER2 Inhibitor with Activity in Lung Cancer. [PDF]

Cancer Discov
Siegel F, Siegel S, Kotýnková K, Karsli Uzunbas G, Korr D, Tomono H, Andersen S, Denney D, Berger M, Schulze VK, Lewis TA, Kaplan B, Golfier S, Mortier J, Hillig RC, Boemer U, Petersen K, Eis K, Williams S, Rüttinger D, Cherniack AD, Loong HH, Goto K, Grassi P, Meyerson M, Greulich H.   +25 more
europepmc   +1 more source

NS398 induces apoptosis in non-small cell lung cancer cells

, 2011
Rong Qiu, Jian Chen, Jun Sima, Xiangdi Shen, Dandan Liu, Jian Shen   +5 more
openalex   +2 more sources